Discover trends, market shifts, and competitive outlooks for the genital herpes industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Fast Is The Genital Herpes Market Expected to Grow Between 2025 And 2029?

In recent years, the market size for genital herpes has seen substantial growth. There will be a rise from $2.19 billion in 2024 to $2.34 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.1%. The increase during the historical time frame can be ascribed to heightened consciousness and detection, progressive developments in therapy, better healthcare accessibility, public health initiatives, and social-demographic elements.

Expectations of robust expansion in the genital herpes market size are predicted in the years to come. With a compound annual growth rate (CAGR) of 6.8%, it is expected to reach $3.05 billion in value by 2029. This prospective growth during the forecast period is primarily attributable to rising awareness levels and enhanced education, advancements in treatments and immunizations, an increasing number of cases, digital healthcare technologies, enlarged accessibility to healthcare, and emergent Sexually Transmitted Infections (STI) enlightenment tact. Foreseen trends during this period involve the use of telemedicine, advances in antiviral therapies, innovative research, and developments in vaccines, an uptick in healthcare accessibility, amplified public awareness initiatives, along with the application and incorporation of Artificial Intelligence and data analytics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp

What Are the Core Growth Drivers Propelling the Genital Herpes Market Forward?

The escalating emphasis on sexual health is projected to thrust the growth of the genital herpes market in the future. The growing attention to sexual health originates from the increased acknowledgment of its vital part in overall health and life quality. The sexual health services for genital herpes mainly include diagnosis, therapy, counseling, and continued monitoring to assist individuals in managing flare-ups, preventing spread, and handling emotional and relationship issues related to the disease. For example, in January 2024, the demand for sexual health services reported an upsurge according to the Local Government Association, a UK-based nationwide membership organization, with approximately 4.5 million assessments conducted in 2022, indicating a 33% growth. Furthermore, diagnostic testing experienced notable activity, with 2.2 million tests executed in 2022, showcasing a 13% swell compared to 2021. Hence, the escalating emphasis on sexual health will stimulate the growth of the genital herpes market.

Which Key Market Segments Comprise the Genital Herpes Market and Drive Its Revenue Growth?

The genital herpes market covered in this report is segmented –

1) By Type: Diagnosis, Treatment

2) By Route Of Administration: Oral, Injectable, Topical

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel

Subsegments:

1) By Diagnosis: Polymerase Chain Reaction (PCR) Tests, Viral Culture Tests, Blood Antibody Tests (Serology), Antigen Detection Tests, Point-Of-Care Rapid Tests

2) By Treatment: Antiviral Medications, Acyclovir, Valacyclovir, Famciclovir, Topical Treatments, Acyclovir Cream, Docosanol Cream, Preventive Therapies, Suppressive Therapy, Prophylactic Vaccines (Under Development), Pain Management Medications, Analgesics, Topical Anesthetics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17161&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Genital Herpes Market?

North America was the largest region in the genital herpes market in 2023. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Genital Herpes Industry Evolution?

Leading businesses within the genital herpes market are leveraging strategic partnerships to advance their technological prowess and expand their market penetration. A strategic collaboration usually involves two or more firms pooling their resources, expertise, and endeavors to reach shared aims. For instance, in June 2022, Eurocine Vaccines AB, a Swedish biotech firm specializing in herpes therapy treatments and products, declared a research and partnership deal with Redbiotec AG, a Swiss biotechnology firm. This contract grants Eurocine Vaccines exclusive worldwide rights for the development, production, and sale of vaccine candidates aimed at targeting Herpes Simplex Virus Type 2 (HSV-2), involving both mRNA and protein-based technologies. This includes associated paperwork and patents within the HSV-2 space. Eurocine Vaccines will be responsible for managing and financing all the development, manufacturing and commercialization steps until an ensuing out-licensing agreement with another party is signed.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

How Is the Genital Herpes Market Conceptually Defined?

Genital herpes refers to a sexually transmitted infection (STI) caused primarily by the herpes simplex virus type 2 (HSV-2) or, less commonly, by the herpes simplex virus type 1 (HSV-1). It typically manifests as sores or blisters on the genital area, buttocks, or anal region. Genital herpes is transmitted through sexual contact with an infected person and can be managed with antiviral medications to reduce symptoms and prevent transmission to sexual partners.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17161

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model